Study 200195 App’s purpose is to support GSK Study 200195 (Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Registry for Patients Treated with Strimvelis™ (or GSK269273) Gene Therapy: Long-Term Prospective, Non-Interventional Follow-up of Safety and Effectiveness). Registry participant’s will be able to use the app to enter the required information for the study.
This version of Study 200195 App Android App comes with one universal variant which will work on all the Android devices.
If you are looking to download other versions of Study 200195 App Android App, We have 1 version in our database. Please select one of them below to download.